Copyright Reports & Markets. All rights reserved.

Global 10-Deacetylbaccatin III Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global 10-Deacetylbaccatin III Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global 10-Deacetylbaccatin III Consumption 2014-2024
        • 2.1.2 10-Deacetylbaccatin III Consumption CAGR by Region
      • 2.2 10-Deacetylbaccatin III Segment by Type
        • 2.2.1 ≥95%
        • 2.2.2 ≥98.0%
        • 2.2.3 Others
      • 2.3 10-Deacetylbaccatin III Consumption by Type
        • 2.3.1 Global 10-Deacetylbaccatin III Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global 10-Deacetylbaccatin III Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global 10-Deacetylbaccatin III Sale Price by Type (2014-2019)
      • 2.4 10-Deacetylbaccatin III Segment by Application
        • 2.4.1 Production of Docetaxel
        • 2.4.2 Production of Paclitaxel
        • 2.4.3 Others
      • 2.5 10-Deacetylbaccatin III Consumption by Application
        • 2.5.1 Global 10-Deacetylbaccatin III Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global 10-Deacetylbaccatin III Value and Market Share by Application (2014-2019)
        • 2.5.3 Global 10-Deacetylbaccatin III Sale Price by Application (2014-2019)

      3 Global 10-Deacetylbaccatin III by Players

      • 3.1 Global 10-Deacetylbaccatin III Sales Market Share by Players
        • 3.1.1 Global 10-Deacetylbaccatin III Sales by Players (2017-2019)
        • 3.1.2 Global 10-Deacetylbaccatin III Sales Market Share by Players (2017-2019)
      • 3.2 Global 10-Deacetylbaccatin III Revenue Market Share by Players
        • 3.2.1 Global 10-Deacetylbaccatin III Revenue by Players (2017-2019)
        • 3.2.2 Global 10-Deacetylbaccatin III Revenue Market Share by Players (2017-2019)
      • 3.3 Global 10-Deacetylbaccatin III Sale Price by Players
      • 3.4 Global 10-Deacetylbaccatin III Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global 10-Deacetylbaccatin III Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players 10-Deacetylbaccatin III Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 10-Deacetylbaccatin III by Regions

      • 4.1 10-Deacetylbaccatin III by Regions
        • 4.1.1 Global 10-Deacetylbaccatin III Consumption by Regions
        • 4.1.2 Global 10-Deacetylbaccatin III Value by Regions
      • 4.2 Americas 10-Deacetylbaccatin III Consumption Growth
      • 4.3 APAC 10-Deacetylbaccatin III Consumption Growth
      • 4.4 Europe 10-Deacetylbaccatin III Consumption Growth
      • 4.5 Middle East & Africa 10-Deacetylbaccatin III Consumption Growth

      5 Americas

      • 5.1 Americas 10-Deacetylbaccatin III Consumption by Countries
        • 5.1.1 Americas 10-Deacetylbaccatin III Consumption by Countries (2014-2019)
        • 5.1.2 Americas 10-Deacetylbaccatin III Value by Countries (2014-2019)
      • 5.2 Americas 10-Deacetylbaccatin III Consumption by Type
      • 5.3 Americas 10-Deacetylbaccatin III Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC 10-Deacetylbaccatin III Consumption by Countries
        • 6.1.1 APAC 10-Deacetylbaccatin III Consumption by Countries (2014-2019)
        • 6.1.2 APAC 10-Deacetylbaccatin III Value by Countries (2014-2019)
      • 6.2 APAC 10-Deacetylbaccatin III Consumption by Type
      • 6.3 APAC 10-Deacetylbaccatin III Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe 10-Deacetylbaccatin III by Countries
        • 7.1.1 Europe 10-Deacetylbaccatin III Consumption by Countries (2014-2019)
        • 7.1.2 Europe 10-Deacetylbaccatin III Value by Countries (2014-2019)
      • 7.2 Europe 10-Deacetylbaccatin III Consumption by Type
      • 7.3 Europe 10-Deacetylbaccatin III Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa 10-Deacetylbaccatin III by Countries
        • 8.1.1 Middle East & Africa 10-Deacetylbaccatin III Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa 10-Deacetylbaccatin III Value by Countries (2014-2019)
      • 8.2 Middle East & Africa 10-Deacetylbaccatin III Consumption by Type
      • 8.3 Middle East & Africa 10-Deacetylbaccatin III Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 10-Deacetylbaccatin III Distributors
      • 10.3 10-Deacetylbaccatin III Customer

      11 Global 10-Deacetylbaccatin III Market Forecast

      • 11.1 Global 10-Deacetylbaccatin III Consumption Forecast (2019-2024)
      • 11.2 Global 10-Deacetylbaccatin III Forecast by Regions
        • 11.2.1 Global 10-Deacetylbaccatin III Forecast by Regions (2019-2024)
        • 11.2.2 Global 10-Deacetylbaccatin III Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global 10-Deacetylbaccatin III Forecast by Type
      • 11.8 Global 10-Deacetylbaccatin III Forecast by Application

      12 Key Players Analysis

      • 12.1 SM Herbals
        • 12.1.1 Company Details
        • 12.1.2 10-Deacetylbaccatin III Product Offered
        • 12.1.3 SM Herbals 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 SM Herbals News
      • 12.2 Alchem International
        • 12.2.1 Company Details
        • 12.2.2 10-Deacetylbaccatin III Product Offered
        • 12.2.3 Alchem International 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Alchem International News
      • 12.3 Indena
        • 12.3.1 Company Details
        • 12.3.2 10-Deacetylbaccatin III Product Offered
        • 12.3.3 Indena 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Indena News
      • 12.4 South Pharmaceutical
        • 12.4.1 Company Details
        • 12.4.2 10-Deacetylbaccatin III Product Offered
        • 12.4.3 South Pharmaceutical 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 South Pharmaceutical News
      • 12.5 HAOXUAN
        • 12.5.1 Company Details
        • 12.5.2 10-Deacetylbaccatin III Product Offered
        • 12.5.3 HAOXUAN 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 HAOXUAN News
      • 12.6 Yuannan Hande
        • 12.6.1 Company Details
        • 12.6.2 10-Deacetylbaccatin III Product Offered
        • 12.6.3 Yuannan Hande 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Yuannan Hande News
      • 12.7 Sai Phytoceuticals
        • 12.7.1 Company Details
        • 12.7.2 10-Deacetylbaccatin III Product Offered
        • 12.7.3 Sai Phytoceuticals 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Sai Phytoceuticals News
      • 12.8 Sarv Biolabs Pvt
        • 12.8.1 Company Details
        • 12.8.2 10-Deacetylbaccatin III Product Offered
        • 12.8.3 Sarv Biolabs Pvt 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Sarv Biolabs Pvt News
      • 12.9 Aphios
        • 12.9.1 Company Details
        • 12.9.2 10-Deacetylbaccatin III Product Offered
        • 12.9.3 Aphios 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Aphios News
      • 12.10 Hainan Yew Pharmaceutical
        • 12.10.1 Company Details
        • 12.10.2 10-Deacetylbaccatin III Product Offered
        • 12.10.3 Hainan Yew Pharmaceutical 10-Deacetylbaccatin III Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Hainan Yew Pharmaceutical News

      13 Research Findings and Conclusion

      This report studies the 10-Deacetylbaccatin III market. 10-Deacetylbaccatin III, also known as 10-DAB or 10-DAB III, is a closely related natural organic compounds isolated from dried needles and small branches of the European yew tree (Taxus baccata).10-Deacetylbaccatin III is a precursor to the anti-cancer drug docetaxel (Taxotere). pacitaxel (taxol); cabazitaxel. 10-10-deacetylbaccatin III was found to selectively inhibit the growth of L. DONOVANI intracellular amastigotes within J774 murine macrophages in vitro at nanomolar concentrations with an IC(50) value of 70 nM.
      As new companies enter the market for finished paclitaxel, bulk demand will increase as competition forces down prices, the study notes, adding that, with the drug becoming more affordable, physicians are expected to prescribe it more freely. However, while demand may be rising, paclitaxel is derived from a natural resource, and its long-term availability is in question.
      Yew trees are slow-growing, and the extraction process requires numerous trees to supply an adequate amount, it says. The possible scarcity of the product is spurring sales, especially to the research sector where large stocks are necessary for proper experimentation. However, the report notes that enterprising companies have found ways to circumvent this issue and increase supply.
      With advances in technology, new and better ways of extracting paclitaxel have evolved, with plant cell culture techniques and genetic engineering also emerging as fruitful methods of enhancing production says F&S. These methods have resulted in ample and continuous supplies, which is expected to boost the quantities of bulk paclitaxel, and subsequently augment the revenues generated by finished products, the report adds.

      According to this study, over the next five years the 10-Deacetylbaccatin III market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 74 million by 2024, from US$ 58 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 10-Deacetylbaccatin III business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of 10-Deacetylbaccatin III market by product type, application, key manufacturers and key regions and countries.

      This study considers the 10-Deacetylbaccatin III value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      ≥95%
      ≥98.0%
      Others
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Production of Docetaxel
      Production of Paclitaxel
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      SM Herbals
      Alchem International
      Indena
      South Pharmaceutical
      HAOXUAN
      Yuannan Hande
      Sai Phytoceuticals
      Sarv Biolabs Pvt
      Aphios
      Hainan Yew Pharmaceutical

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global 10-Deacetylbaccatin III consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of 10-Deacetylbaccatin III market by identifying its various subsegments.
      Focuses on the key global 10-Deacetylbaccatin III manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the 10-Deacetylbaccatin III with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of 10-Deacetylbaccatin III submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now